.png){kind=icon}
Return
Pharmacy 3D printing
.png){kind=icon}
OA
AI
DOI：10.1088/1758-5090/ad837a.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
A significant limitation of the 'one size fits all' medication approach is the lack of consideration for special population groups. 3D printing technology has revolutionised the landscape of pharmaceuticals and pharmacy practice, playing an integral role in enabling on-demand production of customised medication. Compared to traditional pharmaceutical processes, 3D printing has major advantages in producing tailored dosage forms with unique drug release mechanisms. Moreover, this technology has enabled the combination of multiple drugs in a single formulation addressing key issues of medication burden. Development of 3D printing in pharmacy applications and large-scale pharmaceutical manufacturing has substantially increased in recent years. This review focuses on the emergence of extrusion-based 3D printing, particularly semi solid extrusion, fused deposition modelling and direct powder extrusion, which are currently the most commonly studied for pharmacy practice. The concept of each technique is summarised, with examples of current and potential applications. Next, recent advancements in the 3D printer market and pharmacist perceptions are discussed. Finally, the benefits, challenges and prospects of pharmacy 3D printing technology are highlighted, emphasising its significance in changing the future of this field.
Keywords:
3D printing
additive manufacturing
pharmacy practice
semi solid extrusion
fused deposition modelling
direct powder extrusion
Journal
IF:
8
Papers:
1.6K
Citations:
9.3K
Organization
Cited Papers
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.png)
HematologyOAAI
HematologyIF0
OAAIShareSaveShareSaveNovel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament-Investigation of Materials, Process, and Product CharacteristicsPHARMACEUTICS
OAAI
PHARMACEUTICSIF5.5
OAAIShareSaveShareSave
View more